ST13P15

Across TCGA pan-cancer cohorts, ST13P15 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of ST13P15’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where ST13P15 RNA is repressed in tumor relative to normal tissue. In most cancer types ST13P15 is over-expressed in tumor, although a few such as KIRP and BRCA show the opposite, repressed pattern.

KIRP, KIRC, and BRCA are the cancer types where ST13P15 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ST13P15 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	−0.341	<.001	7	view →
KIRC	All	All	+0.268	<.001	5	view →
BRCA	Female	II,III,IV	−0.393	<.001	4	view →
LUSC	All	All	+0.203	.008	3	view →
LIHC	All	All	+0.177	.013	3	view →
UCEC	All	All	−0.544	<.001	2	view →
READ	All	III,IV	+0.375	.032	2	view →
COAD	Female	IV	−0.530	.042	1	view →
LUAD	All	All	+0.169	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

ST13P15–KIRP

Open the KIRP breakdown →